Osaic Holdings’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $376 | Sell |
200
-200
| -50% | -$376 | ﹤0.01% | 6897 |
|
|
2025
Q1 | $1.02K | Buy |
400
+200
| +100% | +$512 | ﹤0.01% | 6659 |
|
|
2024
Q4 | $376 | Hold |
200
| – | – | ﹤0.01% | 6903 |
|
|
2024
Q3 | $204 | Sell |
200
-1,400
| -88% | -$1.43K | ﹤0.01% | 6948 |
|
|
2024
Q2 | $1.87K | Hold |
1,600
| – | – | ﹤0.01% | 6453 |
|
|
2024
Q1 | $2.02K | Sell |
1,600
-500
| -24% | -$630 | ﹤0.01% | 6308 |
|
|
2023
Q4 | $3.74K | Sell |
2,100
-100
| -5% | -$178 | ﹤0.01% | 6192 |
|
|
2023
Q3 | $3.65K | Buy |
2,200
+1,600
| +267% | +$2.66K | ﹤0.01% | 6315 |
|
|
2023
Q2 | $1.2K | Sell |
600
-1
| -0.2% | -$2 | ﹤0.01% | 6693 |
|
|
2023
Q1 | $1.26K | Buy |
601
+101
| +20% | +$212 | ﹤0.01% | 6763 |
|
|
2022
Q4 | $685 | Buy |
+500
| New | +$685 | ﹤0.01% | 7011 |
|
|
2021
Q2 | – | Sell |
-122,184
| Closed | -$545K | – | 7008 |
|
|
2021
Q1 | $545K | Buy |
+122,184
| New | +$545K | ﹤0.01% | 2786 |
|
|
2020
Q4 | – | Sell |
-100
| Closed | – | – | 6403 |
|
|
2020
Q3 | $0 | Buy |
+100
| New | – | ﹤0.01% | 6240 |
|